產(chǎn)品詳情
簡單介紹：
Anti-phospho-Akt(Thr308)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-Akt(Thr308)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-Akt(Thr308)
Cat. Number:
Anti-phospho-Akt(Thr308)抗體XY-2720R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The serine-threonineAnti-phospho-Akt(Thr308)抗體 protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]
Also known as:
Anti-phospho-Akt(Thr308)抗體AKT (phospho T308); p-AKT (phospho T308); Akt(Phospho-Thr308); Akt(Phospho T308); C AKT; MGC9965; Oncogene AKT1; PKB; PRKBA; Protein Kinase B Alpha; RAC Alpha; RAC; RAC PK Alpha; RAC Serine/Threonine Protein Kinase; vAKT Murine Thymoma Viral Oncogene Homolog 1; AKT1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Sheep, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Akt around the phosphorylation site of Thr308.
●
Predicted Molecular Weight: 56kDa.
Storage:
Shipped at 4℃, Anti-phospho-Akt(Thr308)抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must beAnti-phospho-Akt(Thr308)抗體 determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must beAnti-phospho-Akt(Thr308)抗體 determined by the end user.
xy-13930R CHST11碳水化合物磺基轉(zhuǎn)移酶11抗體
xy-13931R CHST12碳水化合物磺基轉(zhuǎn)移酶12抗體
xy-13932R CHST13碳水化合物磺基轉(zhuǎn)移酶13抗體
xy-13933R CHST14碳水化合物磺基轉(zhuǎn)移酶14抗體
xy-13934R CHST2碳水化合物磺基轉(zhuǎn)移酶2抗體
xy-13935R CHST3碳水化合物磺基轉(zhuǎn)移酶3抗體
xy-13936R CHST5碳水化合物磺基轉(zhuǎn)移酶5抗體
xy-13937R CHST6碳水化合物磺基轉(zhuǎn)移酶6抗體
xy-13916R CHMP7染色質(zhì)修飾蛋白CHMP7抗體
xy-13918R CHODL軟骨凝集蛋白CHODL抗體
xy-13919R CCK39膽囊收縮素39抗體
xy-13921R Choline kinase alpha乙醇胺激酶α抗體
xy-6422R CATSPER4陽離子通道精子相關(guān)蛋白4抗體
xy-10470R DYNC1I1胞漿動(dòng)力蛋白中間鏈1抗體
xy-10471R DYNC1I2胞漿動(dòng)力蛋白中間鏈2抗體
xy-2686R DKK3抑癌蛋白DKK3抗體
xym-0356M Digoxin(2E2)地高辛單克隆抗體
xy-2083R DcR1腫瘤壞死因子配體超家族成員10C
xy-1863R DNAJC3干擾素誘導(dǎo)蛋白p58ipk抗體
xy-3659R DACH2轉(zhuǎn)錄調(diào)節(jié)因子DACH2抗體
xy-2423R DLK1穿膜蛋白DLK1抗體
xy-2429R DysferlinDysferlin蛋白抗體
xy-1295R Defensin Beta 2防御素β2/Defensin β2抗體
xy-1350R DAP5死亡相關(guān)蛋白5抗體
xy-3764R DDX19B解旋酶DEAD5抗體
xy-2557R DC-SIGN細(xì)胞間粘附分子非整合素蛋白3抗體
xy-0043R DFFBCaspase 激活的脫氧核糖核酸酶抗體
xy-7062R DEDD1死亡效應(yīng)結(jié)構(gòu)域蛋白1抗體
xy-7063R DEDD2死亡效應(yīng)結(jié)構(gòu)域蛋白2抗體
xy-8525R DNA Polymerase betaDNA聚合酶β抗體
xy-1975R DAXX死亡相關(guān)蛋白6/Fas死亡區(qū)相關(guān)蛋白抗體
